Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, ...

The prosecutor-led program continues her look into juvenile justice. It also continues a state-wide examination of the impact ...

Grieving parents of children killed by fentanyl pills say the Trump administration has the potential to address the nation's drug epidemic.

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...

Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023 ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Governor Jared Polis delivered his 2025 State of the State address before the state legislature on Thursday morning, ...

Once confined to the province of abstract theory, quantum computing seeks to use operations based on quantum mechanics to ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

On January 8, 2025, the Department of Justice (“DOJ”) published its Final Rule to implement President Biden’s Executive Order 14117, ...